This stock should not trade at 10x after the plant upgrades. 7x to 8x is more appropriate given small cap and low liquidity.Current upside imho is 8c. Anything above that use a trailing stop loss.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress